Welcome to ASCO Connection Discussion

Filter by Practice
Florian Mugioiu
Apr 27, 2017 11:28 AM
50 years caucasian female
oct 2015 
left axilary lymphadenopathy, US breast BIRADS 5 (6mm mass), breast MRI (20 mm) BIRADS 5, CT (axillar adenopathy, I,II,III STATIONS without secondary lesions)
nov 2015
breast and nodal biopsy
Breast: NST carcinoma, ER 90%, PGR 85%, HER 2 neu 1+(neg), Ki 67 10%....
Anne Katz, PhD, RN, FAAN
Aug 26, 2016 1:08 PM
Scalp cooling has been shown to be somewhat effective in preventing chemotherapy-related alopecia. What do you recommend to your patients, especially women with breast cancer? Does your infusion center or chemotherapy unit allow or promote this? How many patients use this and what are the patient...
Mark R. Hutchins, MD
Apr 26, 2016 10:50 PM
Has there ever been a PRCT of AC/T vs "other" in a pure TNBC stratified group (in the NeoAdj setting or the Adj setting?) showing that AC/T vs "other" showed a superior survival? When we say that AC/T shows a survival advantage, advantage over what?
The origninal AC vs CMF showed little if any...
Arsh Singh, MD
Jan 18, 2016 1:00 PM
In a 33 y/o caucasian woman with T2N0 Her 2 Positive invasive ductal carcinoma (both by IHC and FISH), ER 50% and PR negative, is it okay to use AC followed by T along with herceptin and pertuzumab  in the neoadjuvant setting?


Tweets from ASCO

Tweets from Oncology Community